Company Updates
Imugene Signs Three Existing Institutional Shareholders
Imugene is pleased to announce that is has signed underwriting agreements with three existing institutional shareholders of IMU to underwrite up to A$1.35 million of options.
YPB Continue to Fight Counterfeit for the Benefit of Brands
YPB has recently released their annual report ending for 2016.
Intermin Resources Announces Results of Goongarrie Lady Scoping Study
Intermin Resources Limited (ASX:IRC) is pleased to announce the results of the Goongarrie Lady Scoping Study.
SUDA LTD Announces Feasibility Agreement with Pfizer
SUDA LTD (ASX: SUD), leaders in the oro-mucosal drug delivery, announced that it has entered into a feasibility agreement with Pfizer consumer Healthcare.
Thinxtra’s Sigfox Technology to Monitor School Signs in New Zealand
Thinxtra’s Sigfox network now covers 88 per cent of the New Zealand population, from Invercargill to Whangarei.
OncoSil Medical Limited recruits for Global Pancreatic Clinical Study Programme
OncoSil announce Monash Health has recruited the first subject for its global clinical study program in pancreatic cancer.
DomaCom Talks of New Partnerships
DomaCom Limited (ASX:DCL) is a securitisation platform, whose job is to take large assets and divide them into “bite sized chunks” for investors, particularly focusing on the financial adviser market.
Domacom Crowdfunding Platform Purchase First Rural Property
Domacom Crowdfunding has purchased a farm near Casterton in what is believed to be the first time a rural property has been sold through the method.
Frost & Sullivan Identifies Proteomics International Laboratories as World-Leader in Predictive Diagnostics for Diabetic Kidney Disease
PILL managing director Dr Richard Lipscombe will be showcasing PromarkerD at the China-Australia Biotech Investment forum in Shanghai today.
Backed By Leading Investment Groups and Family Offices
